SoftBank plans US IPO for new AI and robotics spinout Roze at ~$100bn valuation
Masayoshi Son targets a listing as soon as this year for the standalone entity carved out of SoftBank Group.
Briefing
- •SoftBank Group is creating a standalone AI and robotics company named Roze, with a US IPO targeted as soon as 2026.
- •SoftBank is weighing a valuation of approximately $100 billion for the new entity.
- •The listing would give Roze an independent market presence separate from SoftBank Group's existing conglomerate and Vision Fund structure.
- •No further financial details, lead underwriters, or composition of Roze's asset base were disclosed in the sourced reports.
Analysis
- →A $100bn Roze IPO in 2026 would be the largest AI-themed listing attempted to date, arriving in a market where OpenAI just missed revenue targets and investor appetite for pre-revenue AI entities at frontier valuations is being stress-tested. SoftBank spinning out Roze also reduces the valuation opacity discount embedded in 9984 itself, but only if the IPO clears at or near the targeted figure. A failed or repriced Roze listing would compound SoftBank's existing credibility damage from Vision Fund write-downs and accelerate discount widening on the parent.
- →Separating Roze from SoftBank's conglomerate structure is a direct response to the persistent holding-company discount on 9984, where Vision Fund losses have obscured underlying asset value. A successful Roze IPO at scale provides a public market reference price for SoftBank's AI and robotics assets, mechanically compressing that discount. However, the OpenAI revenue miss story has already repriced AI demand assumptions, meaning the window for achieving a $100bn anchor valuation without demonstrated revenue is narrower now than it would have been six months ago.
Historical Context
- 2024-2025
SoftBank's Vision Fund accumulated over $50bn in cumulative losses through 2023-2024, widening the holding-company discount on 9984 and pressuring Masayoshi Son to restructure the group's AI exposure into more legible, independently valued entities. The Roze spinout is a direct structural response to that discount problem.
- 2019
WeWork's failed IPO, backed by SoftBank at a $47bn valuation, demonstrated the market's willingness to reject high-profile Son-endorsed listings when revenue trajectories did not support headline valuations. Roze faces the same scrutiny framework, particularly given the OpenAI revenue miss resetting AI demand expectations.
Connected Events
OpenAI misses revenue and user targets ahead of IPO push
OpenAI missing revenue and user targets ahead of its own IPO push directly weakens the pricing environment for any AI-themed listing at triple-digit billion valuations. Roze will be benchmarked against OpenAI's disclosed shortfalls by institutional allocators evaluating the 2026 AI IPO cohort.
X-energy raises $1bn in record nuclear IPO, shares surge 27% on debut
X-energy's IPO pricing 40% above range on zero operating assets confirmed that capital markets will price AI and deep-tech optionality aggressively when a credible anchor partner exists. Roze's reception will test whether that appetite extends to robotics and AI without a comparable named customer.
